Han Jing Xie
Chief Tech/Sci/R&D Officer at IDOGEN AB (PUBL)
Profile
Han Jing Xie is an Associate Professor at Karolinska Institutet and the Chief Medical Officer at Idogen AB.
Prior to these roles, Xie was a Senior Director-Medical Study at Oncopeptides AB and the Head-Cancer Clinical Trial Unit at Capio St Gorans Hospital.
Xie earned a doctorate degree from Karolinska Institutet in 2004.
Han Jing Xie active positions
| Companies | Position | Start |
|---|---|---|
| IDOGEN AB (PUBL) | Chief Tech/Sci/R&D Officer | 2021-12-31 |
| Karolinska Institutet | Corporate Officer/Principal | - |
Former positions of Han Jing Xie
| Companies | Position | End |
|---|---|---|
| ONCOPEPTIDES AB | Corporate Officer/Principal | 2021-12-31 |
| Capio St Gorans Hospital | Corporate Officer/Principal | 2019-12-31 |
Training of Han Jing Xie
| Karolinska Institutet | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IDOGEN AB (PUBL) | Health Technology |
| ONCOPEPTIDES AB | Health Technology |
| Private companies | 1 |
|---|---|
| Capio St Gorans Hospital |
- Stock Market
- Insiders
- Han Jing Xie
